Recently, we and others reported the over-expression of PD-L1 in non-Hodgkin lymphoma tumor cells and the increased expression of PD-1 in tumor-infiltrating lymphocytes (TILs) [9, 10, 12, 13]. Here, CD274 is linked to neoplasm.